GMP Registry Update: 16 New Certificates at the Turn of March and April 2026

The Ministry of Industry and Trade of the Russian Federation has added new data to the “Information on Issued, Withdrawn Certificates of Compliance of Manufacturers of Medicinal Products for Medical Use with the Requirements of Good Manufacturing Practice of the Eurasian Economic Union and Certificates Suspended or Terminated.” Between March 30 and April 2, 2026, the regulator issued 16 certificates to Russian and foreign manufacturers. No decisions to refuse issuance were recorded in this update.

Geography and Key Recipients

In late March and early April, the registry was updated with entries for production sites from three countries: Russia, Germany, and Vietnam. A total of 16 sites received positive decisions.

Among Russian companies, manufacturers such as GEROPHARM LLC (several decisions), Velpharm LLC, ARNIKA-PROM-SERVICE LLC, and SPbNIIVS FMBA of Russia FSUE (seven decisions at once) received confirmation of compliance.

The international segment in this update is represented by manufacturers from Vietnam (Dat Vi Phu Pharma Joint Stock Company) and Germany (Bayer AG).

The full list of issued certificates is presented in the table below.

Issued GMP Certificates (30.03.2026 – 02.04.2026)

Production Sites with a Valid EAEU GMP Certificate

According to current data, as of April 2, 2026:

• The total number of GMP certificates with a “Valid” status is 1663;
• The number of sites with a valid GMP certificate (unique address) is 1618;
• The number of companies holding a valid GMP certificate (unique name) is 1079.

Geographical Distribution

Production sites with a valid EAEU GMP certificate are represented by manufacturers from dozens of different countries. Almost half of them are located in Russia.

Source: Unified Register of Drug Manufacturers